{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:46:02Z","timestamp":1793295962899,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-onset preeclampsia (EOPE) is a severe obstetric complication associated with a high risk of adverse maternal and fetal outcomes. Early identification of patients at high risk of adverse pregnancy outcomes may facilitate timely clinical intervention and improve pregnancy management. This study aimed to develop and internally validate a clinical prediction model for adverse pregnancy outcomes in women with EOPE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective observational study included 425 women diagnosed with EOPE who were admitted to a tertiary teaching hospital in Southwest China between January 2018 and December 2025. The composite adverse pregnancy outcome was defined as at least one predefined maternal or fetal\/neonatal adverse event occurring after admission, excluding baseline pregnancy-related complications used as candidate predictors. Patients were randomly divided into a training cohort (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f298) and a validation cohort (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f127). Candidate predictors were restricted to variables measured or diagnosed at admission or within the first 24\u202fh after admission, before the occurrence of the composite adverse pregnancy outcome. Candidate predictors were screened using least absolute shrinkage and selection operator (LASSO) regression and further evaluated using multivariable logistic regression. Independent predictors were used to construct a nomogram-based prediction model. Model performance was evaluated in terms of discrimination, calibration, and clinical utility using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA), with internal validation performed in the split-sample validation cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven predictors were independently associated with the composite adverse pregnancy outcome and were incorporated into the nomogram: gestational age at admission, systolic blood pressure, urine protein score, platelet count, aspartate aminotransferase (AST) level, fetal growth restriction, and hemolysis, elevated liver enzymes, and low platelet syndrome (HELLP) syndrome. In clinically interpretable units, lower gestational age at admission, each 10-mmHg increase in systolic blood pressure, each 1-grade increase in urine protein score, each 50\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L decrease in platelet count, each 10-U\/L increase in AST, fetal growth restriction, and HELLP syndrome were associated with increased risk. The model showed good discrimination, with an area under the curve (AUC) of 0.859 (95% CI: 0.754\u20130.897) in the split-sample validation cohort. Calibration curves showed acceptable agreement between predicted and observed risks, and decision curve analysis suggested potential clinical net benefit across clinically relevant threshold probabilities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed and internally validated a nomogram-based prediction model for adverse pregnancy outcomes in women already diagnosed with EOPE. The model is intended for admission-based risk stratification after EOPE diagnosis, rather than for early prenatal prediction, population screening, or prediction of the initial occurrence of EOPE. The model demonstrated good predictive performance in this single-center cohort and may support clinical risk stratification after external validation. The proposed risk categories are exploratory and should not be used as definitive clinical decision cutoffs without external validation. Independent multicenter validation is required before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1828294","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:57:20Z","timestamp":1781675840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and internal validation of a nomogram for predicting adverse pregnancy outcomes in women with early-onset preeclampsia"],"prefix":"10.3389","volume":"13","author":[{"given":"Haiqiong","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Obstetrics, The Affiliated Hospital, Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Affiliated Hospital, Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"119922","DOI":"10.1016\/j.cca.2024.119922","article-title":"Preeclampsia: a comprehensive review","volume":"563","author":"Ali","year":"2024","journal-title":"Clin Chim Acta"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"102473","DOI":"10.1016\/j.bpobgyn.2024.102473","article-title":"Preventing maternal morbidity and mortality from preeclampsia and eclampsia, particularly in low- and middle-income countries","volume":"94","author":"Ngene","year":"2024","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.3390\/ijms262211091","article-title":"Late vs. early preeclampsia","volume":"26","author":"Kariori","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3390\/ijms25147569","article-title":"A narrative review on the pathophysiology of preeclampsia","volume":"25","author":"Torres-Torres","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2405991","DOI":"10.1080\/10641955.2024.2405991","article-title":"Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia","volume":"43","author":"Rahman","year":"2024","journal-title":"Hypertens Pregnancy"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"936560","DOI":"10.3389\/fcvm.2022.936560","article-title":"Aspirin for the prevention of preeclampsia: a systematic review and meta-analysis of randomized controlled studies","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.preghy.2024.101151","article-title":"Preeclampsia and timing of delivery: disease severity, maternal and perinatal outcomes","volume":"37","author":"Suksai","year":"2024","journal-title":"Pregnancy Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s43032-024-01674-w","article-title":"Comparison of characteristics between early-onset and late-onset severe preeclampsia: a retrospective cohort study from a tertiary Hospital in China","volume":"32","author":"Li","year":"2025","journal-title":"Reprod Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2147\/IJGM.S510654","article-title":"Predictive factors for Fetal growth restriction in patients with preeclampsia: a clinical prediction study","volume":"18","author":"Yan","year":"2025","journal-title":"Int J Gen Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/uog.27490","article-title":"Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis","volume":"63","author":"Tiruneh","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/1471-0528.17983","article-title":"First-trimester prediction models based on maternal characteristics for adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"132","author":"van Eekhout","year":"2025","journal-title":"BJOG"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1510742","DOI":"10.3389\/fmed.2025.1510742","article-title":"Application and progress of nomograms in gastric cancer","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"17455057251348978","DOI":"10.1177\/17455057251348978","article-title":"Predictive modeling of complications arising from early-onset preeclampsia in pregnant women","volume":"21","author":"Dom\u00ednguez Del Olmo","year":"2025","journal-title":"Womens Health"},{"key":"ref14","first-page":"649","article-title":"Gestational hypertension and preeclampsia: a practice Bulletin from ACOG","volume":"100","author":"Croke","year":"2019","journal-title":"Am Fam Physician"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertension"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/AOG.0000000000001108","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.3390\/ijms25084532","article-title":"The pathophysiological, genetic, and hormonal changes in preeclampsia: a systematic review of the molecular mechanisms","volume":"25","author":"Chiang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12884-025-07701-1","article-title":"Role of HMGB1 on the onset of preeclampsia","volume":"25","author":"Y\u0131lmaz","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e081901","DOI":"10.1136\/bmjopen-2023-081901","article-title":"Maternal outcomes of pre-eclampsia with severe features and its determinants at Abebech Gobena mothers and Childrens health and Saint Peter's specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study","volume":"14","author":"Tadese","year":"2024","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1555778","DOI":"10.3389\/fgwh.2025.1555778","article-title":"Maternal outcomes of severe preeclampsia and eclampsia and associated factors among women admitted at referral hospitals of Amhara regional state, institutional-based cross-sectional study","volume":"6","author":"Melesse","year":"2025","journal-title":"North-West Ethiopia Front Glob Womens Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e51512","DOI":"10.7759\/cureus.51512","article-title":"The Management of Preeclampsia: a comprehensive review of current practices and future directions","volume":"16","author":"Sharma","year":"2024","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"101054","DOI":"10.1016\/j.ajpc.2025.101054","article-title":"Preeclampsia: insights into pathophysiological mechanisms and preventive strategies","volume":"23","author":"Martini","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ijgo.15848","article-title":"A prediction model for hemolysis, elevated liver enzymes and low platelets syndrome in pre-eclampsia with severe features","volume":"168","author":"Gilboa","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/AOG.0000000000005819","article-title":"Association of Subcapsular Liver Hematoma with Preeclampsia, eclampsia, or Hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"145","author":"Chahine","year":"2025","journal-title":"Obstet Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.bpobgyn.2023.102426","article-title":"Spiral, uterine artery doppler and placental ultrasound in relation to preeclampsia","volume":"92","author":"de Ganzo","year":"2024","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"26863","DOI":"10.31083\/CEOG26863","article-title":"Clinical value of renal function markers combined with blood lipid levels during late pregnancy to predict preeclampsia: a retrospective case-control study","volume":"52","author":"Zhang","year":"2025","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s43032-023-01330-9","article-title":"Early Fetal growth restriction with or without hypertensive disorders: a clinical overview","volume":"31","author":"Mecacci","year":"2024","journal-title":"Reprod Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"H174","DOI":"10.1152\/ajpheart.00520.2024","article-title":"Impaired maternal central hemodynamics precede the onset of vascular disorders of pregnancy at high altitude","volume":"328","author":"Wiegel","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2505774","DOI":"10.1080\/14767058.2025.2505774","article-title":"Maternal factors and perinatal outcomes associated with early-onset versus late-onset fetal growth restriction: a meta-analysis","volume":"38","author":"Tedyanto","year":"2025","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1186\/s12884-025-08057-2","article-title":"The added value of the sFlt-1\/PlGF ratio in pregnant women with intrauterine growth restriction (IUGR) with or without preeclampsia on adverse pregnancy outcomes and neonatal morbidities: a retrospective study","volume":"25","author":"Arnouts","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"329.e1","DOI":"10.1016\/j.ajog.2025.04.041","article-title":"Antenatal diagnosis of early-onset small for gestational age: absolute and relative risks of adverse outcomes","volume":"233","author":"Liauw","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e1001589","DOI":"10.1371\/journal.pmed.1001589","article-title":"A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (pre-eclampsia integrated estimate of RiSk) multi-country prospective cohort study","volume":"11","author":"Payne","year":"2014","journal-title":"PLoS Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12916-017-0827-3","article-title":"Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models","volume":"15","author":"Thangaratinam","year":"2017","journal-title":"BMC Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1828294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:57:20Z","timestamp":1781675840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1828294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":34,"alternative-id":["10.3389\/fmed.2026.1828294"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1828294","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1828294"}}